Instructor in Psychiatry, Massachusetts General Hospital
Psychiatry
Dr. Cristina Cusin, MD
|
|
Give Review
Cristina Cusin is an expert in the field of Psychiatry. Doctor Cristina Cusin, MD is also a published physician. She has 54 paper published. The most recent paper is: GABAA alpha-1 subunit gene not associated with depressive symptomatology in mood disorders. She is registered with Medicare and accepts Medicare payments.
Publications
- A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive Disorder.
- Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive Disorder: A three week double ...
- Association between physician beliefs regarding assigned treatment and clinical response: Re-analysis of data from the Hypericum Depression Trial Study Group.
- Correlates of irritability in college students with Depressive symptoms.
- A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive Disorder.
- Rapid improvement of depression and psychotic symptoms in Huntington's disease: a retrospective chart review of seven patients treated with electroconvulsive therapy.
- Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive Disorder.
- Etomidate and Ketamine: Residual Motor and Adrenal Dysfunction that Persist beyond Recovery from Loss of Righting Reflex in Rats.
- Complications of carbon monoxide poisoning: a case discussion and review of the literature.
- Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive Disorder.
- Early symptomatic worsening during treatment with fluoxetine in major depressive Disorder: prevalence and implications.
- Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for Major depressive episodes.
- Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis.
- Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive Disorder treated with fluoxetine.
- Is there a placebo problem in antidepressant trials?
- Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.
- Dopamine transporter haplotype and attention-deficit hyperactivity Disorder.
- Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood Disorders.
- Genetic features of antidepressant induced mania and hypo-mania in bipolar Disorder.
- Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by Major depression.
- Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood Disorders.
- SSRIs antidepressant activity is influenced by G beta 3 variants.
- Clinical and demographic features of mood Disorder subtypes.
- Seasonal variations of lithium plasma levels.
- Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
- Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood Disorders.
- Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood Disorders.
- Serotonin transporter gene (5-HTTLPR) and Major psychoses.
- No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.
- Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
- Influence of 5-HTTLPR and TPH variants on illness time course in mood Disorders.
- Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
- Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
- Tryptophan hydroxylase gene and Major psychoses.
- Impact of clinical variables on illness time course in mood Disorders.
- Linkage of mood Disorders with D2, D3 and TH genes: a multicenter study.
- Serotonin-2A receptor gene is not associated with symptomatology of Schizophrenia.
- Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in Schizophrenia.
- Clinical and demographic features of psychotic and nonpsychotic depression.
- No interaction between serotonin transporter gene and dopamine receptor D4 gene in symptomatology of Major psychoses.
- Dopamine D3 receptor gene not associated with symptomatology of Major psychoses.
- Symptomatologic analysis of psychotic and non-psychotic depression.
- Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood Disorders.
- Factor analysis of delusional Disorder symptomatology.
- No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of Major psychoses.
- GABAA alpha-1 subunit gene not associated with depressive symptomatology in mood Disorders.
- Analysis of depressive symptomatology in mood Disorders.
- Dopamine receptor D4 gene is associated with delusional symptomatology in mood Disorders.
- Tyrosine hydroxylase gene associated with depressive symptomatology in mood Disorder.
- Tyrosine hydroxylase gene in linkage disequilibrium with mood Disorders.
- Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.
- Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.
- Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive Disorder.
Procedures Preformed
- Electroconvulsive Therapy (ECT)
Conditions Treated
- Adjustment Disorder
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Massachusetts General Hospital -
University of Milan Faculty of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1003942426 | |
| NPPES Provider LastName | CUSIN | |
| NPPES Provider FirstName | CRISTINA | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 278.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003942426 |
| Last Name Of The Provider | CUSIN |
| First Name Of The Provider | CRISTINA |
| View All |
Similar Doctors
|
|
Dr. Carl R. Schwartz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Querques, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Wolfe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abode L. Hamoush, MD |
|
|
Dr. Anne E. Becker, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gaston C. Baslet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela S. Giacalone, MD |
|
|
Dr. Frances Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen C. Reilly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony T. Marfeo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Owings II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anton Pesok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan R. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heidi W. Ashih, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil Redlener, MD |
|
|
Dr. Tamara D. Almeyda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Esther R. Valdez, MD |
|
|
Dr. Andres A. Eboli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yohanis L. Anglero Diaz, MD |